Butabarbital Shortage Update: What Patients Need to Know in 2026

Patients searching for a "Butabarbital shortage update" in 2026 need to understand an important distinction: Butabarbital is not in a temporary shortage — it has been permanently discontinued from commercial manufacturing in the United States. This difference matters enormously when planning your next steps.

Here is everything you need to know about Butabarbital's current status in 2026, how this situation developed, and what options remain for patients who were relying on this medication.

What Is the Current Status of Butabarbital?

As of 2026, Butabarbital is commercially unavailable in the United States. The brand-name Butisol Sodium has been discontinued by its manufacturer, and no FDA-approved generic version is currently being produced. Both the tablet forms (30 mg and 50 mg) and the oral solution (30 mg/5 mL) have been taken off the market.

The FDA confirmed in October 2020 that the withdrawal of Butisol Sodium was NOT for reasons related to safety or effectiveness — the drug was simply discontinued by manufacturers due to declining prescription volumes.

Shortage vs. Discontinuation: Why the Difference Matters

A drug shortage is a temporary supply problem — demand exceeds what manufacturers can currently produce. The FDA maintains an official drug shortage database, and shortages typically have estimated resolution dates.

A drug discontinuation is different: the product is no longer being made. There is no FDA-registered manufacturer producing Butabarbital for commercial sale. There is no expected restock date. Waiting for it to return to your local pharmacy is not a viable strategy.

Butabarbital does not appear on the FDA's current drug shortage list. It is classified as a discontinued product.

How Did We Get Here? A Brief Timeline

• Mid-20th century: Barbiturates including Butabarbital are widely prescribed for insomnia and anxiety.
• 1960s–1970s: Benzodiazepines emerge as safer alternatives to barbiturates; barbiturate prescribing begins to decline.
• 1990s–2000s: Z-drugs (zolpidem, eszopiclone) receive FDA approval and become first-line insomnia treatments; Butabarbital use falls sharply.
• October 2020: FDA formally determines that Butisol Sodium withdrawal was not for safety or effectiveness reasons.
• Mid-2020s: All commercially manufactured Butabarbital (brand and generic) exits the US market entirely.
• 2026: No commercial Butabarbital available; compounding pharmacies remain the only source with a valid prescription.

What Can Patients Do Right Now?

You have two main paths forward:

1. Find a compounding pharmacy. Because the FDA did not withdraw Butabarbital for safety reasons, licensed compounding pharmacies can prepare it from raw pharmaceutical ingredients. Not all do, but some specialize in controlled substances and can fill a valid prescription.
2. Switch to an available alternative. Zolpidem, temazepam, eszopiclone, and lorazepam are all widely available at standard pharmacies and can address the same conditions Butabarbital was treating. Talk with your prescriber about which is most appropriate for you.

Important Warning: Do Not Stop Butabarbital Abruptly

If you have been taking Butabarbital regularly and cannot find it, do NOT simply stop taking it without medical guidance. Barbiturate withdrawal can be life-threatening, potentially causing seizures, severe anxiety, and in extreme cases, death. Contact your prescriber immediately if your medication supply is running out so they can develop a safe transition or tapering plan.

How medfinder Can Help

Finding a compounding pharmacy that can fill a Butabarbital prescription requires calls to multiple pharmacies — something that can be exhausting when you are already dealing with a health condition. medfinder calls pharmacies near you on your behalf. You tell us your medication, dose, and location. We call pharmacies and text you back with results.

For a full comparison of alternatives, read: Alternatives to Butabarbital If You Can't Fill Your Prescription.

The Bottom Line for 2026

Butabarbital is not coming back to pharmacy shelves. As of 2026, the only way to obtain it is through a compounding pharmacy with a valid prescription. If that path is not viable for you, working with your prescriber to transition to a commercially available alternative is the safest and most reliable solution. Do not attempt to discontinue this barbiturate without medical supervision.